News
- Newsblog
- Media centre
- Map of services
- Vita magazine
- Healthy living
- A to Z of health tips
- Paint it black
- Let's talk about sex
- Understanding hormone therapy
- What now?
- What's on your plate?
- Coping with chronic pain after breast cancer treatment
- Picture perfect
- Positive thinking
- Take care in the sun
- Top drawer
- CyberKnife radiotherapy
- Altered image
- Book review: Bad Pharma by Ben Goldacre
- Breast reconstruction discussed
- Getting active with breast cancer
- Living wills
- Losing weight safely after breast cancer treatment
- Lymphoedema Breast Cancer App
- Overcoming anxiety
- Speaking about secondary breast cancer
- Real lives
- Tell it like it is
- Putting life back in focus
- Everything changes
- A life less ordinary
- Chat show showstopper
- A Motivating Woman
- Ellie's Story
- Paperback writer
- The Big Reveal
- 'We just clicked'
- Ain't no mountain high enough
- Band of brothers
- Cold comfort
- Courage under fire
- Lights, camera, action
- Maybe baby
- On my terms
- Showing Support
- Side by side
- The kids are alright
- The right fit
- United we stand
- Just the job
- Calendar Girl
- Carry on regardless
- Dee and Kelly share their fashion show experience
- Five years on from breast cancer diagnosis
- Frame of reference
- From inflammatory breast cancer to the catwalk
- Going back to work after treatment
- Helping younger women with breast cancer
- It's all in the family
- Keeping up appearances
- Knit one, help one
- Mum’s breast cancer diagnosis brought us closer together
- My life with secondary breast cancer
- Naomi talks about secondary breast cancer
- Pathway to a new life
- Thin Wire by Christine Lewry: an extract
- Trying to move on after treatment
- Walking to raise awareness of breast cancer
- Your questions answered
- Good food
- Vita cooks
- Vita bloggers
- Receive each issue by post
- Current and past issues
- In touch
- Healthy living
@BCCare tweets
| Shining a light on secondary breast cancer http://t.co/mWUsSuic ~ @LizzieMagnusson & @LouRall talk about what you can do this October — 35 weeks 6 days ago |
| Congrats to @N1kkiRogers, winner of the #WinBurgenBread comp! Free Burgen Bread for a year. Lots of tuna & mayo & sweetcorn sandwiches — 35 weeks 6 days ago |
| Thanks to everyone that has supported Secondary Breast Cancer Awareness Day so far http://t.co/zKrvMRbB You can too #spotlight — 35 weeks 6 days ago |
| From Monday to Sunday, what does it mean to live with a diagnosis of secondary breast cancer? http://t.co/dMVx7DtE #spotlight — 35 weeks 6 days ago |
| @Kelly_Byrne2012 Excellent Kelly. Thank you for signing up - can't wait to see how you celebrate & pics of everyone dressed up partying — 35 weeks 6 days ago |
Our comment on NICE consultation over updated guidance on familial breast cancer
Jackie Harris, Clinical Nurse Specialist for Breast Cancer Care, said:
'This proposed new guidance is very good news for people with hereditary breast and a family history of breast cancer which greatly increases the risk of getting the disease.
'The guidance will potentially allow those women who are moderate and high risk breast cancer gene carriers to take tamoxifen or raloxifene where appropriate for five years with the aim of preventing breast cancer, which would be a great step forward. This has been happening in other countries but not the UK to date.
'Increased screening with mammography for longer for both women at an increased risk (moderate, high risk and BRCA carriers) and for those after a diagnosis of breast cancer who are high risk or confirmed BRCA 1 and 2 gene carriers is something that we would also welcome. Many of those affected tell us how much they would appreciate this.
'It could mean more people whose BRCA 1 and 2 mutation carrier probability risk is between 5 and 10% may have the opportunity to consider genetic testing. And genetic testing could also be considered where a first degree relative who has had breast cancer (with a carrier probability of 10-20%) is unavailable for genetic testing.
'Women under 40 newly diagnosed with triple negative breast cancers could be referred to a genetic team for further assessment for the first time.
'We are also pleased to see that the guidance encourages the additional use of computer calculation models alongside family history when making a risk assessment, allowing for greater accuracy and potentially better tailored treatments.
'We will be responding in detail to these proposals after full consideration. What we must ensure is that anyone offered or informed about any of these options is given the support and information they need and that support organisations like Breast Cancer Care are signposted every step of the way.'
Notes to editors:
For further media information, please contact:
Sophie Howells/Sophie Softley Pierce
0207 960 3450/0207 960 3505
sophie.howells@breastcancercare.org.uk/sophie.pierce@breastcancercare.org.uk
About Breast Cancer Care
When breast cancer and its treatment overshadow everything, we see the woman underneath. Breast Cancer Care is the only UK-wide charity dedicated to providing emotional and practical support for anyone affected. Our free Helpline, information-packed website and online forums offer a friendly ear and expert information to those dealing with this life-threatening disease. Across the UK we offer a range of confidential, face-to-face services for people living with and beyond breast cancer. We campaign for better support and care and promote the importance of early detection, involving people with breast cancer in all that we do.Visit www.breastcancercare.org.uk or call our free Helpline on 0808 800 6000.



Re: Our comment on NICE consultation over updated guidance ...
Interesting response. I welcome any innovations but I thought that the majority of inherited breast cancers in younger women were triple negative so I can't see how Tamoxifen helps.